Skip to content
Home
LIVE · CORPUS
Dossier

Bock - Emil Ekkehardt

High
OrganizationBM
/01

At a glance

Dimensions on file
Subsidiaries
37

High-risk entity

Flagged in the current sources. Risk levels are investigative leads, not legal determinations — see the detail below.

/02

Key facts

Risk signal

Bock - Emil Ekkehardt is a Organization registered in BM resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers

None in current sources.

/04

Directorship network

269 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

TRIANGLE INTERNATIONAL REINSURANCE LIMITED
Novartis International Pharmaceutical Ltd.
Novartis B3 Ltd.
Triangle Management Limited
Novartis B1 Ltd.
Syngenta Investment Ltd.
Novartis Bioventures Ltd.
Novartis Securities Investment Ltd.
Novartis B2 Ltd.
Novartis Venture Capital Management Ltd.
Novartis Nutrition Finance Ltd.
Novartis Finance Services Ltd.
Novartis Overseas Ltd.
Sandoz Investment US Ltd.
Genova Ltd.
Novartis International Pharmaceutical Investment Ltd.
CBT Bermuda Holdings Ltd.
Novartis Investment, Ltd.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Bock - Emil Ekkehardt. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnakeScore.

Sign in to contribute a tip and earn reputation — it's free.
Loading tips…